Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Data Animal Data In pregnant rats given twice weekly subcutaneous doses of 0.02, 0.1, and 0.5 mg/kg tirzepatide [0.03-, 0.07-, and 0.5-fold the maximum recommended human dose (MRHD) of 15 mg once weekly based on AUC] during organogenesis, increased incidences of external, visceral, and skeletal malformations, increased incidences of visceral and skeletal developmental variations, and decreased fetal weights coincided with pharmacologically-mediated reductions in maternal body weights and food consumption at 0.5 mg/kg
Maternal thyroid disease in the Danish National Birth Cohort: prevalence and risk factors
Why Choose the Retatrutide Starter Kit
How is eligibility determined when choosing between the Wegovy pill and the Wegovy injection
These scientific reports showed that GLP-1s have no negative impact on hormones, sexual function or sperm quality
